Chromosome 5 Suppresses Tumorigenicity of PC3 Prostate Cancer Cells: Correlation with Re-Expression of α-Catenin and Restoration of E-Cadherin Function

Cancer Research

Volumn 55, Issue 21, 1995, Pages 4813-4817

  Ewing, Charles M ^a   Ru, Ning ^a   Robinson, John C ^a   Isaacs, William B ^a   Wheelock, Margaret J ^b   Johnson, Keith R ^b   Barrett, J Carl ^c   Morton, Ronald A ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOLEDO   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; CYTOPLASM PROTEIN; UVOMORULIN;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL ADHESION; CHROMOSOME 5; CONTROLLED STUDY; GENE DELETION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMAL; CADHERINS; CELL ADHESION; CELL COMMUNICATION; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 5; CYTOSKELETAL PROTEINS; DNA; GENE EXPRESSION; HUMAN; MALE; MICE; MICE, NUDE; PHENOTYPE; PROSTATIC NEOPLASMS; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0028883898     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science (Washington DC), 251: 1451–1455, 1991.
2. Kemier, R. From Cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends. Genet., 9: 317–321, 1993.
3. Tsukita, S., Nagafuchi, A., and Yonemura, S. Molecular linkage between Cadherins and actin filaments in cell-cell adherens junctions. Curr. Opin. Cell Biol., 4: 834–839,1992.
4. Takeichi, M. The Cadherin cell adhesion receptor family: roles in multicellular organization and neurogenesis. Prog. Clin. Biol. Res., 390: 145–153, 1994.
5. Birchmeier, W., and Behrens, J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta, 1198: 11–26, 1994.
6. Shiozaki, H., Tahara, H., Oka, H., Miyata, M., Kobayashi, K., Tamura, S., Iihara, K., Doki, Y., Hirano, S., Takeichi, M., and Mori, T. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am. J. Pathol., 139: 17–23, 1991.
7. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and van Roy, F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66: 107–119, 1991.
8. Alcaraz, A., Takahashi, S., Brown, J. A., Herath, J. F., Bergstralh, E. J., Larson-Keller, J. J., Lieber, M. M., and Jenkins, R. B. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res., 54: 3998–4002, 1994.
9. Takeichi, M. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol., 5: 806–811, 1993.
10. Ozawa, M., Baribault, H., and Kemier, R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J., 8: 1711–1717, 1989.
11. Gumbiner, B. M., and McCrea, P. D. Catenins as mediators of the cytoplasmic functions of Cadherins. J. Cell Sci. Suppl., 17: 155–158, 1993.
12. Wheelock, M. J., and Knudsen, K. A. Cadherins and associated proteins. In Vivo, 5: 505–513, 1991.
13. Hulsken, J., Birchmeier, W., and Behrens, J. E-Cadherin and APC compete for the interaction with α-catenin and the cytoskeleton. J. Cell Biol., 127: 2061–2069,1994.
14. Takeichi, M., Hirano, S., Matsuyoshi, N., and Fujimori, T. Cytoplasmic control of cadherin-mediated cell-cell adhesion. Cold Spring Harbor Symp. Quant. Biol., 57: 327–334, 1992.
15. Knudsen, K. A., Soler, A. P., Johnson, K. R., and Wheelock, M. J. Interaction of α-actinin with the cadherin/catenin cell-cell adhesion complex via α-catenin. J. Cell Biol., 130: 67–77, 1995.
16. Herrenknecht, K., Ozawa, M., Eckerskorn, C., Lottspeich, F., Lenter, M., and Kemier, R. The uvomorulin-anchorage protein α-catenin is a vinculin homologue. Proc. Natl. Acad. Sci. USA, 88: 9156–9160, 1991.
17. Nagafuchi, A., Takeichi, M., and Tsukita, S. The 102 kd cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression. Cell, 65: 849–857, 1991.
18. Umbas, R., Schalken, J. A., Aalders, T. W., Carter, B. S., Karthaus, H. F., Schaafsma, H. E., Debruyne, F. M., and Isaacs, W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res., 52: 5104–5109, 1992.
19. Umbas, R., Isaacs, W. B., Bringuier, P. P., Schaafsma, H. E., Karthaus, H. F., Oosterhof, G. O., Debruyne, F. M., and Schalken, J. A. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res., 54: 3929–3933, 1994.
20. Morton, R. A., Ewing, C. M., Nagafuchi, A., Tsukita, S., and Isaacs, W. B. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells. Cancer Res., 53: 3585–3590, 1993.
21. Furukawa, Y., Nakatsuru, S., Nagafuchi, A., Tsukita, S., Muto, T., Nakamura, Y., and Horii, A. Structure, expression and chromosome assignment of the human catenin (cadherin-associated protein) a 1 gene (CTNNA1). Cytogenet. Cell Genet., 65: 74–78, 1994.
22. McPherson, J. D., Morton, R. A., Ewing, C. M., Wasmuth, J. J., Overhauser, J., Nagafuchi, A., Tsukita, S., and Isaacs, W. B. Assignment of the human α-catenin gene (CTNNA1) to chromosome 5q21-q22. Genomics, 19: 188–190, 1994.
23. Kaighn, M. E., Narayan, K. S., Ohnuki, Y., Lechner, J. F., and Jones, L. W. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest. Urol., 17: 16–23, 1979.
24. Iizumi, T., Yazaki, T., Kanon, S., Kondo, I., and Koiso, K. Establishment of a new prostatic carcinoma cell line (TSU-Prl). J. Urol., 137: 1304–1306, 1987.
25. Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K., and Vogelstem, B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (Washington DC), 249: 912–915, 1990.
26. Isaacs, W. B., Carter, B. S., and Ewing, C. M. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res., 51: 4716–4720,1991.
27. Koi, M., Shimizu, M., Morita, H., Yamada, H., and Oshimura, M. Construction of mouse A9 clones containing a single human chromosome tagged with neomycin-resistance gene via microcell fusion. Jpn. J. Cancer Res., 80: 413–418, 1989.
28. Ichikawa, T., Ichikawa, Y., Dong, J., Hawkins, A. L., Griffin, C. A., Isaacs, W. B., Oshimura, M., Barrett, J. C., and Isaacs, J. T. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res., 52: 3486–3490, 1992.
29. Isaacs, J. T., and Coffey, D. S. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res., 41: 5070–5075, 1981.
30. Shimoyama, Y., and Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 57: 2185–2192, 1991.
31. Johnson, K. R., Lewis, J. E., Li, D., Wahl, J., Soler, A. P., Knudsen, K. A., and Wheelock, M. J. P- and E-cadherin are in separate complexes in cells expressing both Cadherins. Exp. Cell Res., 207: 252–260, 1993.
32. Bussemakers, M. J., van Moorselaar, R. J., Giroldi, L. A., Ichikawa, T., Isaacs, J. T., Takeichi, M., Debruyne, F. M., and Schalken, J. A. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res., 52:2916–2922,1992.
33. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I., and Isaacs, W. B. Allelic loss of chromosomes 16q and lOq in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751–8755, 1990.
34. Su, L. K., Vogelstein, B., and Kinzler, K. W. Association of the APC tumor suppressor protein with catenins. Science (Washington DC), 262: 1734–1737, 1993.
35. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., and Polakis, P. Association of the APC gene product with β-catenin. Science (Washington DC), 262: 1731–1734, 1993.
36. Smith, K. J., Johnson, K. A., Bryan, T. M., Hill, D. E., Markowitz, S., Willson, J. K., Paraskeva, C., Petersen, G. M., Hamilton, S. R., Vogelstein, B., et al. The APC gene product in normal and tumor cells. Proc. Natl. Acad. Sci. USA, 90: 2846–2850,1993.
37. Watabe, M., Nagafuchi, A., Tsukita, S., and Takeichi, M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J. Cell Biol., 127: 247–256, 1994.
38. Yunis, J. J., and Soreng, A. L. Constitutive fragile sites and cancer. Science (Washington DC), 226: 1199–1204, 1984.
39. Visakorpi, T., Kallioniemi, A. H., Syvanen, A. C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O. P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342–347, 1995.
40. Nollet, F., van Hengel, J., Berx, G., Molemans, F., and Van Roy, F. Isolation and characterization of a human pseudogene (CTNNAP1) for alphα-catenin (CTNNA1): assignment of the pseudogene to 5q22 and the alpha E-catenin gene to 5q31. Genomics, 26: 410–413, 1995.